(1S,3R,6R,7R,10R,11R)-6-[(E,2R,5R)-5,6-Dimethylhept-3-en-2-yl]-7,11-dimethyl-2-oxapentacyclo[8.8.0.01,3.03,7.011,16]octadec-15-ene-1 4,17-dione

CAS : 1265908-20-0

Ref. 3D-QAC90820

Informations sur le produit

• Nom: (1S,3R,6R,7R,10R,11R)-6-[(E,2R,5R)-5,6-Dimethylhept-3-en-2-yl]-7,11-dimethyl-2-oxapentacyclo[8.8.0.01,3.03,7.011,16]octadec-15-ene-1 4,17-dione
• Synonymes: Ergosta-4,22-diene-3,6-dione, 8,14-epoxy-, (14β,22E)-, (14β,22E)-8,14-Epoxyergosta-4,22-diene-3,6-dione

Description

(1S,3R,6R,7R,10R,11R)-6-[(E,2R,5R)-5,6-Dimethylhept-3-en-2-yl]-7,11-dimethyl-2-oxapentacyclo[8.8.0.01,3.03,7.011,16]octadec-15-ene-1 4,17-dione is a potent inhibitor of protein kinases that has been shown to have medicinal properties in the treatment of cancer cells and tumors. This compound inhibits the activity of several key proteins involved in the cell cycle and has been found to induce apoptosis in both Chinese hamster ovary cells and human cancer cell lines. Additionally, this compound has demonstrated anticancer activity in animal models and is excreted in urine following administration. The inhibition of protein kinases by (1S,3R,6R,7R,10R,

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 424.6 g/mol
• Formule: C₂₈H₄₀O₃
• Degré de pureté: Min. 95%